Month: November 2021

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

2024.03.12
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

2023.11.13
Genomtec received positive evaluation of Grant in Oncology Diagnostics from the Polish Agency for Enterprise Development (PARP) and the European Funds for a Modern Economy program

2023.11.13
Genomtec S.A. expands its Genomtec ID platform to oncology and has filed a patent application specific to oncology diagnostics

Archive

2021.11.30

Genomtec’s laboratory genetic test detects all variants of SARS-CoV-2 including Omicron

Genomtec has conducted an analysis of its rapid genetic tests that confirmed their effectiveness in detecting all known variants of the ...
Read
2021.11.29

Genomtec files a new patent application in the UK

Genomtec has filed a patent application entitled “Thermal interface arrangement” for a proprietary method of heat transfer and ...
Read
2021.11.25

Miron Tokarski Awarded with Laureate of “Leaders of the Future” Ranking by Forbes

Miron Tokarski, co-founder and CEO of Genomtec, found himself among the honourable laureates of the Forbes Magazine ranking: “Leaders of ...
Read
2021.11.19

Genomtec receives sixth patent protecting the Company’s technology for HPV-16 genetic diagnostics

Genomtec has received patent protection from the Polish Patent Office for a primer set for the detection of Human papillomavirus-16 (HPV16), a ...
Read
2021.11.08

Genomtec gets closer to commercializing its Genomtec®ID platform – Q3 2021 summary

Genomtec released its Q3 2021 report. Q3 was a period of intensified work on Genomtec®ID – the company obtained 2 additional patents (in ...
Read
2021.11.03

Genomtec to accelerate commercialization of Genomtec®ID

Genomtec started today the analysis to accelerate the planned commercialization of the Genomtec®ID platform. The analysis will include the ...
Read

Archive